Ayman Sahli joined Gulf Pharmaceuticals Industries Julphar in 2008 as general manager. But, having excelled in leading the company and strengthening its operations through networking with various countries and their respective pharmaceuticals markets, Sahli was appointed as CEO.

He is a holder of a doctorate in chemistry and specialises in pharmaceutical research and manufacturing. All efforts have placed Julphar on the podium, as the Sheikh Mohammed Bin Rashid Business Award for the best company in the industry sector, was collected. This year, the company announced plans to begin work on three plants worth over $70m.